SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $392,000 | -14.6% | 15,569 | -29.4% | 0.03% | +86.7% |
| Q3 2020 | $459,000 | -87.2% | 22,037 | -85.4% | 0.02% | -83.9% |
| Q2 2020 | $3,590,000 | -45.1% | 151,166 | -58.4% | 0.09% | -45.9% |
| Q1 2020 | $6,534,000 | -19.5% | 363,200 | +6.1% | 0.17% | +50.9% |
| Q4 2019 | $8,121,000 | -43.5% | 342,351 | -34.6% | 0.11% | -32.9% |
| Q3 2019 | $14,384,000 | +16.3% | 523,425 | +40.0% | 0.17% | -29.2% |
| Q2 2019 | $12,371,000 | +16.4% | 373,866 | +23.3% | 0.24% | +12.1% |
| Q1 2019 | $10,628,000 | +11.6% | 303,300 | +5.8% | 0.21% | +4.4% |
| Q4 2018 | $9,527,000 | +698.6% | 286,785 | +1110.7% | 0.20% | +720.0% |
| Q3 2018 | $1,193,000 | +122.2% | 23,688 | +164.1% | 0.02% | +78.6% |
| Q2 2018 | $537,000 | -23.8% | 8,971 | -41.7% | 0.01% | -30.0% |
| Q1 2018 | $705,000 | – | 15,395 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |